Contact this trialFirst, we need to learn more about you.
Hormone Therapy
Niraparib + Abiraterone Acetate + Prednisone for Prostate Cancer
Recruiting1 awardPhase 2
Dallas, Texas
This trial will test a new treatment in 64 people with advanced prostate cancer who have specific genetic changes. The study is open to people who have not received treatment before for their cancer.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service